Literature DB >> 33310895

'Triple therapy' (elexacaftor, tezacaftor, ivacaftor) skin rash in patients with cystic fibrosis.

May Khei Hu1, Genna Wood2, Owen Dempsey2.   

Abstract

Entities:  

Keywords:  cystic fibrosis

Mesh:

Substances:

Year:  2020        PMID: 33310895     DOI: 10.1136/postgradmedj-2020-139264

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  1 in total

1.  Rechallenge of Elexacaftor/Tezacaftor/Ivacaftor After Skin Rash in Two Pediatric Patients.

Authors:  Emily R Diseroad; Peter J Mogayzel; Alice Pan
Journal:  J Pediatr Pharmacol Ther       Date:  2022-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.